Ludwig J Horst
Overview
Explore the profile of Ludwig J Horst including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
40
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Horst L, Zimmermann K, Lutz J, Weidemann S, Luth S, Lohse A, et al.
Liver Int
. 2025 Feb;
45(3):e70037.
PMID: 39969799
Background And Aims: Sarcoidosis is a granulomatous multi-systemic disorder of uncertain aetiology frequently involving the liver. This study aimed to delineate the histological characteristics, treatment effectiveness and factors predictive of...
2.
Horst L, Kempski J, Walmsley M, Huber S, Schramm C
Hepatology
. 2025 Jan;
PMID: 39841598
Primary sclerosing cholangitis is one of the most challenging conditions in hepatology, and due to our limited understanding of its pathogenesis, no causal therapies are currently available. While it was...
3.
Roth D, Dull M, Horst L, Lindemann A, Malzer X, Koop K, et al.
J Crohns Colitis
. 2024 Aug;
19(2).
PMID: 39212221
Background: Recently, autoantibodies directed against the epithelial adhesion protein integrin αVβ6 have been identified that are strongly associated with ulcerative colitis (UC). We aimed to elucidate whether anti-integrin αVβ6 (anti-αVβ6)...
4.
Horst L, Weidemann S, Lohse A, Sebode M
Z Rheumatol
. 2022 Jun;
81(7):567-576.
PMID: 35763059
Hepatic granulomas can have various causes and their detection requires a systematic diagnostic evaluation. First, identification of risk factors for granulomatous diseases and the exclusion of extrahepatic organ manifestation are...
5.
Liu H, Koch C, Haller A, Joosse S, Kumar R, Vellekoop M, et al.
Adv Biosyst
. 2020 Apr;
4(2):e1900162.
PMID: 32293134
The capture of circulating tumor cells (CTCs) is still a challenging application for microfluidic chips, as these cells are rare and hidden in a huge background of blood cells. Here,...
6.
Koch C, Joosse S, Schneegans S, Wilken O, Janning M, Loreth D, et al.
Cancers (Basel)
. 2020 Feb;
12(2).
PMID: 32069934
Circulating tumor cells (CTCs) are promising tools for risk prediction and the monitoring of response to therapy in cancer patients. Within the EU/IMI CANCER-ID consortium, we validated CTC enrichment systems...
7.
Joosse S, Beyer B, Gasch C, Nastaly P, Kuske A, Isbarn H, et al.
Clin Chem
. 2019 Oct;
66(1):161-168.
PMID: 31601564
Background: Transrectal ultrasound-guided prostate biopsy (TRUS) is a standard procedure for prostate cancer diagnosis. Because prostate cancer is a multifocal disease in many patients, multiple sampling (n ≥ 10) is...